Boyer David W. sold $609K of NBIX
Boyer David W. (Chief Corp. Affairs Officer) sold 3,888 shares of NEUROCRINE BIOSCIENCES INC (NBIX) at $156.64 ($0.61M total) on 2026-05-26 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed event is an open-market sale by a corporate affairs officer under a pre-arranged 10b5-1 plan, which generally carries less informational content than unscheduled selling.
Market read
For NBIX, this is primarily a sentiment datapoint rather than a fundamental catalyst.
What to watch
The article provides no context on total insider holdings beyond post-transaction shares, no buy activity, and no linkage to any concurrent operational or clinical catalyst.
Background
The article is an SEC Form 4 disclosure for an insider transaction at Neurocrine Biosciences, reported via EDGAR.
Ticker impact
Neurocrine Biosciences insider David W. Boyer sold 3,888 shares at $156.6418 on a 10b5-1 plan, totaling about $609K.
Likely minimal price impact; any reaction should be short-lived unless accompanied by other company-specific news.
The filing is a Form 4 insider transaction and explicitly states a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
No direct sector read-through; this is company-specific insider liquidity activity.
None indicated.
None indicated.
Counterpoint
Traders may overreact to insider selling; because it is 10b5-1, it may reflect diversification or tax planning rather than bearish fundamentals.
Key entities
- issuerNEUROCRINE BIOSCIENCES INC
Subject of the Form 4 insider transaction disclosure.
- insiderBoyer David W.
Chief Corp. Affairs Officer who sold shares under a Rule 10b5-1 plan.
